HEADER HYDROLASE 04-OCT-04 1XMU TITLE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH TITLE 2 ROFLUMILAST COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B; COMPND 5 SYNONYM: DPDE4, PDE32; COMPND 6 EC: 3.1.4.17; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B; COMPND 12 SYNONYM: DPDE4, PDE32; COMPND 13 EC: 3.1.4.17; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDE4B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON PLUS(RIL); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: PDE4B; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON PLUS(RIL); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS PHOSPHODIESTERASE, PDE, PDE4B, ROFLUMILAST, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU, AUTHOR 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG,M.V.MILBURN, AUTHOR 3 S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG REVDAT 4 13-JUL-11 1XMU 1 VERSN REVDAT 3 06-OCT-09 1XMU 1 HETNAM REVDAT 2 24-FEB-09 1XMU 1 VERSN REVDAT 1 14-DEC-04 1XMU 0 JRNL AUTH G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU, JRNL AUTH 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG, JRNL AUTH 3 M.V.MILBURN,S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG JRNL TITL STRUCTURAL BASIS FOR THE ACTIVITY OF DRUGS THAT INHIBIT JRNL TITL 2 PHOSPHODIESTERASES. JRNL REF STRUCTURE V. 12 2233 2004 JRNL REFN ISSN 0969-2126 JRNL PMID 15576036 JRNL DOI 10.1016/J.STR.2004.10.004 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.25 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 35524 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1874 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2660 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2850 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5307 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 79 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.25000 REMARK 3 B22 (A**2) : 1.71000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.316 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.232 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.161 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.722 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5474 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4836 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7421 ; 1.394 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11268 ; 1.048 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 652 ; 3.034 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 837 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6052 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1081 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1286 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5460 ; 0.217 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3051 ; 0.099 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 126 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.072 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.161 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 41 ; 0.320 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3267 ; 0.581 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5299 ; 1.139 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2207 ; 1.776 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2116 ; 2.967 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 155 A 193 REMARK 3 RESIDUE RANGE : A 195 A 431 REMARK 3 RESIDUE RANGE : A 433 A 485 REMARK 3 ORIGIN FOR THE GROUP (A): 1.8541 2.6796 53.0128 REMARK 3 T TENSOR REMARK 3 T11: 0.1505 T22: 0.0916 REMARK 3 T33: 0.1132 T12: -0.0223 REMARK 3 T13: 0.0279 T23: 0.0078 REMARK 3 L TENSOR REMARK 3 L11: 1.4714 L22: 0.3800 REMARK 3 L33: 1.3845 L12: 0.1279 REMARK 3 L13: 0.0130 L23: 0.1402 REMARK 3 S TENSOR REMARK 3 S11: -0.0051 S12: 0.0684 S13: -0.1660 REMARK 3 S21: 0.1236 S22: -0.0695 S23: -0.0052 REMARK 3 S31: 0.0461 S32: -0.1191 S33: 0.0746 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 163 B 193 REMARK 3 RESIDUE RANGE : B 195 B 319 REMARK 3 RESIDUE RANGE : B 321 B 485 REMARK 3 ORIGIN FOR THE GROUP (A): 42.3709 2.5940 52.3363 REMARK 3 T TENSOR REMARK 3 T11: 0.1233 T22: 0.0672 REMARK 3 T33: 0.1331 T12: 0.0081 REMARK 3 T13: 0.0336 T23: 0.0931 REMARK 3 L TENSOR REMARK 3 L11: 1.9391 L22: 0.3214 REMARK 3 L33: 1.8784 L12: -0.4174 REMARK 3 L13: -0.3886 L23: 0.1645 REMARK 3 S TENSOR REMARK 3 S11: -0.0012 S12: 0.0215 S13: -0.1012 REMARK 3 S21: -0.0574 S22: -0.1020 S23: 0.0054 REMARK 3 S31: 0.0128 S32: 0.1470 S33: 0.1032 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XMU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-NOV-04. REMARK 100 THE RCSB ID CODE IS RCSB030528. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 10 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BLU-ICE REMARK 200 DATA SCALING SOFTWARE : ELVES REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35524 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 70.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.56800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE AND LITHIUM SULFATE , REMARK 280 PH 10, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.65800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.01300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.01300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.65800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS ONE MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 131 REMARK 465 GLY A 132 REMARK 465 SER A 133 REMARK 465 SER A 134 REMARK 465 HIS A 135 REMARK 465 HIS A 136 REMARK 465 HIS A 137 REMARK 465 HIS A 138 REMARK 465 HIS A 139 REMARK 465 HIS A 140 REMARK 465 SER A 141 REMARK 465 SER A 142 REMARK 465 GLY A 143 REMARK 465 LEU A 144 REMARK 465 VAL A 145 REMARK 465 PRO A 146 REMARK 465 ARG A 147 REMARK 465 GLY A 148 REMARK 465 SER A 149 REMARK 465 HIS A 150 REMARK 465 MET A 151 REMARK 465 SER A 152 REMARK 465 ILE A 153 REMARK 465 SER A 154 REMARK 465 GLN A 486 REMARK 465 SER A 487 REMARK 465 PRO A 488 REMARK 465 SER A 489 REMARK 465 PRO A 490 REMARK 465 PRO A 491 REMARK 465 LEU A 492 REMARK 465 ASP A 493 REMARK 465 GLU A 494 REMARK 465 GLN A 495 REMARK 465 ASN A 496 REMARK 465 ARG A 497 REMARK 465 ASP A 498 REMARK 465 CYS A 499 REMARK 465 GLN A 500 REMARK 465 GLY A 501 REMARK 465 LEU A 502 REMARK 465 MET A 503 REMARK 465 GLU A 504 REMARK 465 LYS A 505 REMARK 465 PHE A 506 REMARK 465 GLN A 507 REMARK 465 PHE A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 THR A 511 REMARK 465 LEU A 512 REMARK 465 ASP A 513 REMARK 465 GLU A 514 REMARK 465 GLU A 515 REMARK 465 ASP A 516 REMARK 465 SER A 517 REMARK 465 GLU A 518 REMARK 465 GLY A 519 REMARK 465 PRO A 520 REMARK 465 GLU A 521 REMARK 465 LYS A 522 REMARK 465 GLU A 523 REMARK 465 GLY A 524 REMARK 465 GLU A 525 REMARK 465 GLY A 526 REMARK 465 HIS A 527 REMARK 465 SER A 528 REMARK 465 MET B 131 REMARK 465 GLY B 132 REMARK 465 SER B 133 REMARK 465 SER B 134 REMARK 465 HIS B 135 REMARK 465 HIS B 136 REMARK 465 HIS B 137 REMARK 465 HIS B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 465 SER B 141 REMARK 465 SER B 142 REMARK 465 GLY B 143 REMARK 465 LEU B 144 REMARK 465 VAL B 145 REMARK 465 PRO B 146 REMARK 465 ARG B 147 REMARK 465 GLY B 148 REMARK 465 SER B 149 REMARK 465 HIS B 150 REMARK 465 MET B 151 REMARK 465 SER B 152 REMARK 465 ILE B 153 REMARK 465 SER B 154 REMARK 465 ARG B 155 REMARK 465 PHE B 156 REMARK 465 GLY B 157 REMARK 465 VAL B 158 REMARK 465 ASN B 159 REMARK 465 THR B 160 REMARK 465 GLU B 161 REMARK 465 ASN B 162 REMARK 465 GLN B 486 REMARK 465 SER B 487 REMARK 465 PRO B 488 REMARK 465 SER B 489 REMARK 465 PRO B 490 REMARK 465 PRO B 491 REMARK 465 LEU B 492 REMARK 465 ASP B 493 REMARK 465 GLU B 494 REMARK 465 GLN B 495 REMARK 465 ASN B 496 REMARK 465 ARG B 497 REMARK 465 ASP B 498 REMARK 465 CYS B 499 REMARK 465 GLN B 500 REMARK 465 GLY B 501 REMARK 465 LEU B 502 REMARK 465 MET B 503 REMARK 465 GLU B 504 REMARK 465 LYS B 505 REMARK 465 PHE B 506 REMARK 465 GLN B 507 REMARK 465 PHE B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 465 THR B 511 REMARK 465 LEU B 512 REMARK 465 ASP B 513 REMARK 465 GLU B 514 REMARK 465 GLU B 515 REMARK 465 ASP B 516 REMARK 465 SER B 517 REMARK 465 GLU B 518 REMARK 465 GLY B 519 REMARK 465 PRO B 520 REMARK 465 GLU B 521 REMARK 465 LYS B 522 REMARK 465 GLU B 523 REMARK 465 GLY B 524 REMARK 465 GLU B 525 REMARK 465 GLY B 526 REMARK 465 HIS B 527 REMARK 465 SER B 528 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 230 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP A 256 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 392 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 375 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 CYS B 390 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 ASP B 419 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 159 150.82 -49.24 REMARK 500 GLU A 163 -71.57 -33.58 REMARK 500 CME A 194 -71.17 -25.50 REMARK 500 ASP A 299 7.45 57.15 REMARK 500 SER A 301 55.82 38.37 REMARK 500 ILE A 450 -57.21 -133.19 REMARK 500 GLN A 463 126.33 -36.42 REMARK 500 SER B 187 33.59 -146.99 REMARK 500 SER B 301 57.15 36.09 REMARK 500 HIS B 319 23.51 -75.08 REMARK 500 CME B 320 -12.06 -152.51 REMARK 500 ASP B 321 92.20 -68.05 REMARK 500 SER B 368 34.89 -82.90 REMARK 500 SER B 369 15.26 -148.87 REMARK 500 ASP B 375 50.72 -109.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 HOH 1003-1009 ARE ASSOCIATED WITH CHAIN A. REMARK 600 HOH 2003-20010 ARE ASSOCIATED WITH CHAIN B. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 238 NE2 REMARK 620 2 HIS A 274 NE2 101.3 REMARK 620 3 ASP A 275 OD2 90.3 88.3 REMARK 620 4 ASP A 392 OD2 91.1 88.1 176.4 REMARK 620 5 HOH A1007 O 166.5 89.7 82.3 97.0 REMARK 620 6 HOH A1008 O 87.6 169.5 97.2 86.2 82.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 275 OD1 REMARK 620 2 HOH A1006 O 92.3 REMARK 620 3 HOH A 8 O 162.7 101.2 REMARK 620 4 HOH A1007 O 89.5 91.3 100.8 REMARK 620 5 HOH A1004 O 88.1 178.0 78.1 90.7 REMARK 620 6 HOH A1005 O 86.8 87.1 83.2 176.0 90.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 238 NE2 REMARK 620 2 HIS B 274 NE2 102.9 REMARK 620 3 ASP B 275 OD2 82.8 90.4 REMARK 620 4 ASP B 392 OD2 92.2 93.6 174.2 REMARK 620 5 HOH B2008 O 162.5 92.6 89.0 95.0 REMARK 620 6 HOH B2009 O 78.6 176.1 86.3 89.9 85.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 275 OD1 REMARK 620 2 HOH B2003 O 85.3 REMARK 620 3 HOH B2004 O 87.2 89.7 REMARK 620 4 HOH B2005 O 157.4 75.9 80.4 REMARK 620 5 HOH B2008 O 99.2 172.9 95.9 100.8 REMARK 620 6 HOH B2006 O 95.2 81.4 170.6 94.2 92.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROF A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROF B 102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XLX RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH CILOMILAST REMARK 900 RELATED ID: 1XLZ RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH FILAMINAST REMARK 900 RELATED ID: 1XM4 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH PICLAMILAST REMARK 900 RELATED ID: 1XM6 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R)-MESOPRAM REMARK 900 RELATED ID: 1XMY RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R)-ROLIPRAM REMARK 900 RELATED ID: 1XN0 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R,S)-ROLIPRAM REMARK 900 RELATED ID: 1XOM RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH CILOMILAST REMARK 900 RELATED ID: 1XON RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH PICLAMILAST REMARK 900 RELATED ID: 1XOQ RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH ROFLUMILAST REMARK 900 RELATED ID: 1XOR RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH ZARDAVERINE REMARK 900 RELATED ID: 1XOS RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH SILDENAFIL REMARK 900 RELATED ID: 1XOT RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH VARDENAFIL REMARK 900 RELATED ID: 1XOZ RELATED DB: PDB REMARK 900 PDE5A IN COMPLEX WITH TADALAFIL REMARK 900 RELATED ID: 1XP0 RELATED DB: PDB REMARK 900 PDE5A IN COMPLEX WITH VARDENAFIL DBREF 1XMU A 152 528 UNP Q07343 PDE4B_HUMAN 324 700 DBREF 1XMU B 152 528 UNP Q07343 PDE4B_HUMAN 324 700 SEQADV 1XMU MET A 131 UNP Q07343 INITIATING METHIONINE SEQADV 1XMU GLY A 132 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 133 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 134 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS A 135 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 136 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 137 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 138 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 139 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS A 140 UNP Q07343 EXPRESSION TAG SEQADV 1XMU SER A 141 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 142 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY A 143 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU LEU A 144 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU VAL A 145 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU PRO A 146 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU ARG A 147 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY A 148 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER A 149 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS A 150 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU MET A 151 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU MET B 131 UNP Q07343 INITIATING METHIONINE SEQADV 1XMU GLY B 132 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 133 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 134 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS B 135 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 136 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 137 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 138 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 139 UNP Q07343 EXPRESSION TAG SEQADV 1XMU HIS B 140 UNP Q07343 EXPRESSION TAG SEQADV 1XMU SER B 141 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 142 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY B 143 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU LEU B 144 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU VAL B 145 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU PRO B 146 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU ARG B 147 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU GLY B 148 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU SER B 149 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU HIS B 150 UNP Q07343 CLONING ARTIFACT SEQADV 1XMU MET B 151 UNP Q07343 CLONING ARTIFACT SEQRES 1 A 398 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 398 LEU VAL PRO ARG GLY SER HIS MET SER ILE SER ARG PHE SEQRES 3 A 398 GLY VAL ASN THR GLU ASN GLU ASP HIS LEU ALA LYS GLU SEQRES 4 A 398 LEU GLU ASP LEU ASN LYS TRP GLY LEU ASN ILE PHE ASN SEQRES 5 A 398 VAL ALA GLY TYR SER HIS ASN ARG PRO LEU THR CME ILE SEQRES 6 A 398 MET TYR ALA ILE PHE GLN GLU ARG ASP LEU LEU LYS THR SEQRES 7 A 398 PHE ARG ILE SER SER ASP THR PHE ILE THR TYR MET MET SEQRES 8 A 398 THR LEU GLU ASP HIS TYR HIS SER ASP VAL ALA TYR HIS SEQRES 9 A 398 ASN SER LEU HIS ALA ALA ASP VAL ALA GLN SER THR HIS SEQRES 10 A 398 VAL LEU LEU SER THR PRO ALA LEU ASP ALA VAL PHE THR SEQRES 11 A 398 ASP LEU GLU ILE LEU ALA ALA ILE PHE ALA ALA ALA ILE SEQRES 12 A 398 HIS ASP VAL ASP HIS PRO GLY VAL SER ASN GLN PHE LEU SEQRES 13 A 398 ILE ASN THR ASN SER GLU LEU ALA LEU MET TYR ASN ASP SEQRES 14 A 398 GLU SER VAL LEU GLU ASN HIS HIS LEU ALA VAL GLY PHE SEQRES 15 A 398 LYS LEU LEU GLN GLU GLU HIS CYS ASP ILE PHE MET ASN SEQRES 16 A 398 LEU THR LYS LYS GLN ARG GLN THR LEU ARG LYS MET VAL SEQRES 17 A 398 ILE ASP MET VAL LEU ALA THR ASP MET SER LYS HIS MET SEQRES 18 A 398 SER LEU LEU ALA ASP LEU LYS THR MET VAL GLU THR LYS SEQRES 19 A 398 LYS VAL THR SER SER GLY VAL LEU LEU LEU ASP ASN TYR SEQRES 20 A 398 THR ASP ARG ILE GLN VAL LEU ARG ASN MET VAL HIS CYS SEQRES 21 A 398 ALA ASP LEU SER ASN PRO THR LYS SER LEU GLU LEU TYR SEQRES 22 A 398 ARG GLN TRP THR ASP ARG ILE MET GLU GLU PHE PHE GLN SEQRES 23 A 398 GLN GLY ASP LYS GLU ARG GLU ARG GLY MET GLU ILE SER SEQRES 24 A 398 PRO MET CME ASP LYS HIS THR ALA SER VAL GLU LYS SER SEQRES 25 A 398 GLN VAL GLY PHE ILE ASP TYR ILE VAL HIS PRO LEU TRP SEQRES 26 A 398 GLU THR TRP ALA ASP LEU VAL GLN PRO ASP ALA GLN ASP SEQRES 27 A 398 ILE LEU ASP THR LEU GLU ASP ASN ARG ASN TRP TYR GLN SEQRES 28 A 398 SER MET ILE PRO GLN SER PRO SER PRO PRO LEU ASP GLU SEQRES 29 A 398 GLN ASN ARG ASP CYS GLN GLY LEU MET GLU LYS PHE GLN SEQRES 30 A 398 PHE GLU LEU THR LEU ASP GLU GLU ASP SER GLU GLY PRO SEQRES 31 A 398 GLU LYS GLU GLY GLU GLY HIS SER SEQRES 1 B 398 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 398 LEU VAL PRO ARG GLY SER HIS MET SER ILE SER ARG PHE SEQRES 3 B 398 GLY VAL ASN THR GLU ASN GLU ASP HIS LEU ALA LYS GLU SEQRES 4 B 398 LEU GLU ASP LEU ASN LYS TRP GLY LEU ASN ILE PHE ASN SEQRES 5 B 398 VAL ALA GLY TYR SER HIS ASN ARG PRO LEU THR CME ILE SEQRES 6 B 398 MET TYR ALA ILE PHE GLN GLU ARG ASP LEU LEU LYS THR SEQRES 7 B 398 PHE ARG ILE SER SER ASP THR PHE ILE THR TYR MET MET SEQRES 8 B 398 THR LEU GLU ASP HIS TYR HIS SER ASP VAL ALA TYR HIS SEQRES 9 B 398 ASN SER LEU HIS ALA ALA ASP VAL ALA GLN SER THR HIS SEQRES 10 B 398 VAL LEU LEU SER THR PRO ALA LEU ASP ALA VAL PHE THR SEQRES 11 B 398 ASP LEU GLU ILE LEU ALA ALA ILE PHE ALA ALA ALA ILE SEQRES 12 B 398 HIS ASP VAL ASP HIS PRO GLY VAL SER ASN GLN PHE LEU SEQRES 13 B 398 ILE ASN THR ASN SER GLU LEU ALA LEU MET TYR ASN ASP SEQRES 14 B 398 GLU SER VAL LEU GLU ASN HIS HIS LEU ALA VAL GLY PHE SEQRES 15 B 398 LYS LEU LEU GLN GLU GLU HIS CME ASP ILE PHE MET ASN SEQRES 16 B 398 LEU THR LYS LYS GLN ARG GLN THR LEU ARG LYS MET VAL SEQRES 17 B 398 ILE ASP MET VAL LEU ALA THR ASP MET SER LYS HIS MET SEQRES 18 B 398 SER LEU LEU ALA ASP LEU LYS THR MET VAL GLU THR LYS SEQRES 19 B 398 LYS VAL THR SER SER GLY VAL LEU LEU LEU ASP ASN TYR SEQRES 20 B 398 THR ASP ARG ILE GLN VAL LEU ARG ASN MET VAL HIS CYS SEQRES 21 B 398 ALA ASP LEU SER ASN PRO THR LYS SER LEU GLU LEU TYR SEQRES 22 B 398 ARG GLN TRP THR ASP ARG ILE MET GLU GLU PHE PHE GLN SEQRES 23 B 398 GLN GLY ASP LYS GLU ARG GLU ARG GLY MET GLU ILE SER SEQRES 24 B 398 PRO MET CYS ASP LYS HIS THR ALA SER VAL GLU LYS SER SEQRES 25 B 398 GLN VAL GLY PHE ILE ASP TYR ILE VAL HIS PRO LEU TRP SEQRES 26 B 398 GLU THR TRP ALA ASP LEU VAL GLN PRO ASP ALA GLN ASP SEQRES 27 B 398 ILE LEU ASP THR LEU GLU ASP ASN ARG ASN TRP TYR GLN SEQRES 28 B 398 SER MET ILE PRO GLN SER PRO SER PRO PRO LEU ASP GLU SEQRES 29 B 398 GLN ASN ARG ASP CYS GLN GLY LEU MET GLU LYS PHE GLN SEQRES 30 B 398 PHE GLU LEU THR LEU ASP GLU GLU ASP SER GLU GLY PRO SEQRES 31 B 398 GLU LYS GLU GLY GLU GLY HIS SER MODRES 1XMU CME A 194 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1XMU CME A 432 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1XMU CME B 194 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1XMU CME B 320 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 194 10 HET CME A 432 10 HET CME B 194 10 HET CME B 320 10 HET ZN A1001 1 HET MG A1002 1 HET ZN B1001 1 HET MG B1002 1 HET ROF A 101 26 HET ROF B 102 26 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM ZN ZINC ION HETNAM MG MAGNESIUM ION HETNAM ROF 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4- HETNAM 2 ROF (DIFLUOROMETHOXY)BENZAMIDE HETSYN ROF ROFLUMILAST FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 3 ZN 2(ZN 2+) FORMUL 4 MG 2(MG 2+) FORMUL 7 ROF 2(C17 H14 CL2 F2 N2 O3) FORMUL 9 HOH *79(H2 O) HELIX 1 1 ASN A 162 LEU A 170 1 9 HELIX 2 2 GLU A 171 LEU A 173 5 3 HELIX 3 3 ASN A 179 SER A 187 1 9 HELIX 4 4 ARG A 190 ARG A 203 1 14 HELIX 5 5 ASP A 204 PHE A 209 1 6 HELIX 6 6 SER A 212 ASP A 225 1 14 HELIX 7 7 ASN A 235 SER A 251 1 17 HELIX 8 8 THR A 252 ASP A 256 5 5 HELIX 9 9 THR A 260 HIS A 274 1 15 HELIX 10 10 SER A 282 THR A 289 1 8 HELIX 11 11 SER A 291 ASN A 298 1 8 HELIX 12 12 SER A 301 LEU A 314 1 14 HELIX 13 13 LEU A 315 GLN A 316 5 2 HELIX 14 14 GLU A 317 ASP A 321 5 5 HELIX 15 15 THR A 327 ALA A 344 1 18 HELIX 16 16 THR A 345 SER A 348 5 4 HELIX 17 17 LYS A 349 THR A 363 1 15 HELIX 18 18 ASN A 376 LEU A 393 1 18 HELIX 19 19 SER A 394 LYS A 398 5 5 HELIX 20 20 SER A 399 ARG A 424 1 26 HELIX 21 21 SER A 429 ASP A 433 5 5 HELIX 22 22 SER A 438 ILE A 450 1 13 HELIX 23 23 ILE A 450 VAL A 462 1 13 HELIX 24 24 ALA A 466 SER A 482 1 17 HELIX 25 25 GLU B 163 LEU B 170 1 8 HELIX 26 26 GLU B 171 LEU B 173 5 3 HELIX 27 27 ASN B 179 TYR B 186 1 8 HELIX 28 28 ARG B 190 ARG B 203 1 14 HELIX 29 29 ASP B 204 PHE B 209 1 6 HELIX 30 30 SER B 212 HIS B 226 1 15 HELIX 31 31 ASN B 235 SER B 251 1 17 HELIX 32 32 THR B 252 ASP B 256 5 5 HELIX 33 33 THR B 260 HIS B 274 1 15 HELIX 34 34 SER B 282 THR B 289 1 8 HELIX 35 35 SER B 291 TYR B 297 1 7 HELIX 36 36 SER B 301 LEU B 314 1 14 HELIX 37 37 THR B 327 ALA B 344 1 18 HELIX 38 38 THR B 345 SER B 348 5 4 HELIX 39 39 LYS B 349 THR B 363 1 15 HELIX 40 40 ASN B 376 LEU B 393 1 18 HELIX 41 41 SER B 394 LYS B 398 5 5 HELIX 42 42 SER B 399 ARG B 424 1 26 HELIX 43 43 SER B 429 ASP B 433 5 5 HELIX 44 44 SER B 438 ILE B 450 1 13 HELIX 45 45 ILE B 450 VAL B 462 1 13 HELIX 46 46 ALA B 466 SER B 482 1 17 LINK C THR A 193 N CME A 194 1555 1555 1.32 LINK C CME A 194 N ILE A 195 1555 1555 1.35 LINK C MET A 431 N CME A 432 1555 1555 1.33 LINK C CME A 432 N ASP A 433 1555 1555 1.35 LINK C THR B 193 N CME B 194 1555 1555 1.31 LINK C CME B 194 N ILE B 195 1555 1555 1.35 LINK C HIS B 319 N CME B 320 1555 1555 1.34 LINK C CME B 320 N ASP B 321 1555 1555 1.34 LINK NE2 HIS A 238 ZN ZN A1001 1555 1555 2.16 LINK NE2 HIS A 274 ZN ZN A1001 1555 1555 2.14 LINK OD1 ASP A 275 MG MG A1002 1555 1555 2.11 LINK OD2 ASP A 275 ZN ZN A1001 1555 1555 2.17 LINK OD2 ASP A 392 ZN ZN A1001 1555 1555 2.16 LINK NE2 HIS B 238 ZN ZN B1001 1555 1555 2.20 LINK NE2 HIS B 274 ZN ZN B1001 1555 1555 2.10 LINK OD1 ASP B 275 MG MG B1002 1555 1555 2.06 LINK OD2 ASP B 275 ZN ZN B1001 1555 1555 2.15 LINK OD2 ASP B 392 ZN ZN B1001 1555 1555 2.26 LINK ZN ZN A1001 O HOH A1007 1555 1555 2.05 LINK ZN ZN A1001 O HOH A1008 1555 1555 2.35 LINK MG MG A1002 O HOH A1006 1555 1555 2.21 LINK MG MG A1002 O HOH A 8 1555 1555 2.15 LINK MG MG A1002 O HOH A1007 1555 1555 2.10 LINK MG MG A1002 O HOH A1004 1555 1555 2.05 LINK MG MG A1002 O HOH A1005 1555 1555 2.11 LINK ZN ZN B1001 O HOH B2008 1555 1555 2.14 LINK ZN ZN B1001 O HOH B2009 1555 1555 2.31 LINK MG MG B1002 O HOH B2003 1555 1555 2.10 LINK MG MG B1002 O HOH B2004 1555 1555 2.03 LINK MG MG B1002 O HOH B2005 1555 1555 2.28 LINK MG MG B1002 O HOH B2008 1555 1555 1.92 LINK MG MG B1002 O HOH B2006 1555 1555 2.07 CISPEP 1 GLN A 463 PRO A 464 0 1.63 CISPEP 2 GLN B 463 PRO B 464 0 0.96 SITE 1 AC1 6 HIS A 238 HIS A 274 ASP A 275 ASP A 392 SITE 2 AC1 6 HOH A1007 HOH A1008 SITE 1 AC2 6 HOH A 8 ASP A 275 HOH A1004 HOH A1005 SITE 2 AC2 6 HOH A1006 HOH A1007 SITE 1 AC3 7 HIS B 238 HIS B 274 ASP B 275 ASP B 392 SITE 2 AC3 7 MG B1002 HOH B2008 HOH B2009 SITE 1 AC4 7 ASP B 275 ZN B1001 HOH B2003 HOH B2004 SITE 2 AC4 7 HOH B2005 HOH B2006 HOH B2008 SITE 1 AC5 17 HOH A 8 HOH A 28 HIS A 234 THR A 345 SITE 2 AC5 17 MET A 347 ASP A 392 LEU A 393 ASN A 395 SITE 3 AC5 17 PRO A 396 TYR A 403 TRP A 406 THR A 407 SITE 4 AC5 17 ILE A 410 MET A 411 GLN A 443 PHE A 446 SITE 5 AC5 17 HOH A1006 SITE 1 AC6 17 HOH B 21 HIS B 234 THR B 345 MET B 347 SITE 2 AC6 17 ASP B 392 LEU B 393 ASN B 395 TYR B 403 SITE 3 AC6 17 TRP B 406 THR B 407 ILE B 410 MET B 411 SITE 4 AC6 17 MET B 431 SER B 442 GLN B 443 PHE B 446 SITE 5 AC6 17 HOH B2010 CRYST1 89.316 94.100 108.026 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011196 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010627 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009257 0.00000 MASTER 589 0 10 46 0 0 18 6 0 0 0 62 END